Beam Therapeutics Inc.
BEAM
$23.91
$0.944.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.39% | -20.94% | 6.53% | -6.17% | 7.72% |
| Total Depreciation and Amortization | 0.18% | 1.56% | -0.58% | -1.81% | 2.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -33.43% | -13.54% | 2.21% | 1.01% | -9.77% |
| Change in Net Operating Assets | 113.51% | -22.74% | 18.93% | 1.22% | 31.74% |
| Cash from Operations | 26.41% | -36.04% | 13.34% | -6.16% | 16.78% |
| Capital Expenditure | -2.32% | -3.20% | -88.33% | 19.58% | 19.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.08% | -194.41% | 391.91% | -70.63% | 275.31% |
| Cash from Investing | -36.23% | -199.06% | 411.30% | -71.77% | 263.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -87.85% | 39.55% |
| Issuance of Common Stock | -99.77% | 13,645.03% | 135.41% | 509.58% | -92.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.77% | 13,645.03% | 172.90% | 848.87% | -95.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.55% | 358.04% | 185.83% | -1,446.44% | 103.07% |